In addition, in breast cancer, PCDHB15, a potential tumor suppressor, was reported to be epigenetically silenced via DNA promoter methylation, and it might be an epigenetic biomarker for the diagnosis and prognosis of breast cancer [11]. Here, PCDHB15 is linked to breast cancer.